ADA Scientific Sessions 2026 Abstract

First-in-Human Study of Oral GLP-1 Receptor Agonist RDSY1801

By Weiping Jia, Fei Gao, Jian Zhou, Jian-Ning Liu

Trial in peopleInterventions

The paper

Weiping Jia, Fei Gao, Jian Zhou, Jian-Ning Liu

Shanghai

ADA Scientific Sessions 2026 Abstract, 5 Jun 2026

Presented at ADA Scientific Sessions 2026, late-breaking 2827-LB

doi.org/10.2337/db26-2827-lb

Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes